|Positive ELISA detected in||Recombinant protein|
|Enzyme-linked Immunosorbent Assay (ELISA)||ELISA : |
|Sample-dependent, check data in validation data gallery|
28867-1-AP targets SARS-CoV-2 Spike Glycoprotein (944-1214 aa) in IF,ELISA applications and shows reactivity with Virus samples.
|Host / Isotype||Rabbit / IgG|
|Immunogen||SARS-CoV-2 Spike Glycoprotein (944-1214 aa) fusion protein Ag30685|
|Full Name||SARS-CoV-2 Spike Protein|
|Calculated molecular weight||141 kDa|
|GenBank accession number||NC_045512|
|Gene symbol||COVID-19 S Protein|
|Gene ID (NCBI)||43740568|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
Coronaviruses (CoVs) infect human and animals and cause varieties of diseases, including respiratory, enteric, renal, and neurological diseases. CoV uses its spike protein to recognize ACE2 as its receptors and mediate membrane fusion and virus entry into host cells(PMID: 32221306). Each monomer of trimeric S protein is about 180 kDa, and contains two subunits, S1 and S2,S1 recognizes and binds to host receptors, and subsequent conformational changes in S2 facilitate fusion between the viral envelope and the host cell membrane(PMID: 19198616). Although the amino acid sequences of the S-glycoprotein were found to be different between the various HCoV, the structures showed high similarity, but the best 3D structural overlap shared by SARS-CoV and SARS-CoV-2, consistent with the shared ACE2 predicted receptor (PMID: 32522207). The spike protein of CoVs can be a target for vaccine and therapeutic development (PMID: 19198616). This antibody detects the spike protein of SARS/SARS-COV-2/MERS.